Becton, Dickinson and Company (BD) announced the commercial launch of a new line of high-throughput, robotics-compatible reagent kits designed for automation to ensure consistency and efficiency in single-cell research.
The automated kit is a collaboration between BD and Hamilton that standardizes processes that have traditionally been performed manually, with the aim of accelerating the generation of material for genetic sequencing, BD said in a statement. The kit includes the newly released BD OMICS-One XT WTA Assay and the Hamilton Microlab NGS STAR automated liquid handling platform.
"By automating the complex library preparation process, researchers can scale their sample throughput and expect more consistent results, minimizing the variability introduced by manual procedures," Steve Conly, worldwide president of BD Biosciences, said.
"This standardization is crucial for the reproducibility of experiments, which is a cornerstone of scientific research. The integration of Hamilton's robotics with BD's robotics-ready reagent kits can streamline workflows, reduce the potential for human error, and accelerate the pace of discovery in critical areas such as oncology and immunology."
Moreover, as many labs and other facilities already have the NGS STAR platform installed, researchers can easily integrate the new BD assay into existing workflows across a wide range of genomics applications, BD said.
The BD OMICS-One XT Library Preparation Reagent Kits and Hamilton Microlab NGS STAR are commercially available globally.
